» Articles » PMID: 32411629

Clinicoradiological Features of Resected Serous Cystic Neoplasms According to Morphological Subtype and Preoperative Tentative Diagnosis: Can Radiological Characteristics Distinguish Serous Cystic Neoplasms from Other Lesions?

Overview
Specialty General Surgery
Date 2020 May 16
PMID 32411629
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Serous cystic neoplasm (SCN) of the pancreas is considered benign in most cases. However, some SCN patients undergo surgical resection because lesions could not be differentiated preoperatively. This study evaluated causes of resection for SCN, investigated clinical and radiological features of surgically resected SCNs, and compared characteristics of SCNs diagnosed accurately and those misdiagnosed.

Methods: One hundred patients, who underwent surgery for pancreatic cystic tumors with pathological confirmation of SCN between 2000 and 2014 were retrospectively analyzed.

Results: The mean patient age was 52.9 years, 67 (67%) were female, and most lesions (72%) were located in the pancreatic body or tail. Fifty-one (51%) pathologically confirmed SCNs were preoperatively diagnosed as non-SCNs. Patients underwent surgery due to uncertain diagnosis (58%) or symptomatology (18%). According to radiological examination, most lesions were macrocystic (85%), exhibited septation (58%), or were enhancing lesions (48%). Compared with preoperatively diagnosed non-SCNs, accurately diagnosed SCNs exhibited septation (75.5% 41.2%, P = 0.001) and central scar (36.7% 11.8%, P = 0.003) more frequently in radiological examinations. In terms of macrocystic tumors (n = 85), most parameters did not differentiate preoperative diagnoses, although lesions accurately diagnosed as SCN exhibited septation more frequently than those preoperatively misdiagnosed as mucinous cystic neoplasm or intraductal papillary mucinous neoplasm (70.7% 38.9% 33.3%, respectively, P = 0.009).

Conclusion: It is difficult to accurately distinguish macrocystic SCNs from other cystic tumors using conventional radiological methods. For more accurate diagnosis, new biomarkers and/or other diagnostic modalities are needed and warrant further investigation.

Citing Articles

Morphological characterization of atypical pancreatic ductal adenocarcinoma with cystic lesion on DCE-CT: a comprehensive retrospective study.

Chen J, Wu Q, Liu L, Yuan Y, Lai S, Wu Z BMC Med Imaging. 2025; 25(1):87.

PMID: 40087584 DOI: 10.1186/s12880-025-01586-4.


Misdiagnosis of pancreatic intraductal papillary mucinous neoplasms and the challenge of mimicking lesions: imaging diagnosis and differentiation strategies.

Yasrab M, Kwak S, Khoshpouri P, Fishman E, Zaheer A Abdom Radiol (NY). 2024; .

PMID: 39327307 DOI: 10.1007/s00261-024-04551-x.


Radiomics advances in the evaluation of pancreatic cystic neoplasms.

Mao K, Ma C, Song B Heliyon. 2024; 10(3):e25535.

PMID: 38333791 PMC: 10850586. DOI: 10.1016/j.heliyon.2024.e25535.


Advances in the Diagnosis of Pancreatic Cystic Lesions.

Puscasu C, Rimbas M, Mateescu R, Larghi A, Cauni V Diagnostics (Basel). 2022; 12(8).

PMID: 35892490 PMC: 9394320. DOI: 10.3390/diagnostics12081779.


Updates in diagnosis and management of pancreatic cysts.

Lee L World J Gastroenterol. 2021; 27(34):5700-5714.

PMID: 34629795 PMC: 8473602. DOI: 10.3748/wjg.v27.i34.5700.


References
1.
Sakorafas G, Smyrniotis V, Reid-Lombardo K, Sarr M . Primary pancreatic cystic neoplasms revisited: part II. Mucinous cystic neoplasms. Surg Oncol. 2011; 20(2):e93-101. DOI: 10.1016/j.suronc.2010.12.003. View

2.
Matsumoto T, Hirano S, Yada K, Shibata K, Sasaki A, Kamimura T . Malignant serous cystic neoplasm of the pancreas: report of a case and review of the literature. J Clin Gastroenterol. 2005; 39(3):253-6. DOI: 10.1097/01.mcg.0000152749.64526.38. View

3.
Tseng J, Warshaw A, Sahani D, Lauwers G, Rattner D, Fernandez-Del Castillo C . Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg. 2005; 242(3):413-9. PMC: 1357749. DOI: 10.1097/01.sla.0000179651.21193.2c. View

4.
Bjork Werner J, Bartosch-Harlid A, Andersson R . Cystic pancreatic lesions: current evidence for diagnosis and treatment. Scand J Gastroenterol. 2011; 46(7-8):773-88. DOI: 10.3109/00365521.2011.551892. View

5.
King J, Ng T, White S, Cortina G, Reber H, Hines O . Pancreatic serous cystadenocarcinoma: a case report and review of the literature. J Gastrointest Surg. 2009; 13(10):1864-8. PMC: 2759006. DOI: 10.1007/s11605-009-0926-3. View